Nonmelanoma Skin Cancer Studies
Nonmelanoma Skin Cancer Studies is a research topic within Epidemiology. Science Explorer counts 26k research works in it since 1950. 12.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the epidemiology, risk factors, incidence, and management of various types of skin cancers, including nonmelanoma skin cancer, squamous cell carcinoma, and basal cell carcinoma. It also explores the impact of sun exposure, organ transplant recipients, and the use of treatments such as photodynamic therapy and imiquimod cream. The research covers topics related to prevention, diagnosis, and treatment of skin cancer.
- Skin Cancers
- Nonmelanoma Skin Cancer
- Organ Transplant Recipients
- Actinic Keratoses
- Squamous Cell Carcinoma
- Basal Cell Carcinoma
- Photodynamic Therapy
- Imiquimod Cream
- Metastasis
- Sun Exposure
- Research works
- 26k fractional, since 1950
- In the world top 10%
- 3.1k per year above
- Top-10% rate
- 12.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +39% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Nonmelanoma Skin Cancer Studies research?
By volume, the United States and India publish the most (1.4k and 459 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.4k works
- 2 India 459 works
- 3 China 415 works
- 4 Brazil 240 works
- 5 United Kingdom 240 works
- 6 Italy 231 works
- 7 Germany 200 works
- 8 Spain 175 works
- 9 Japan 158 works
- 10 Australia 153 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Nonmelanoma Skin Cancer Studies research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Nonmelanoma Skin Cancer Studies research, followed by University of Miami and Memorial Sloan Kettering Cancer Center.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 26 works
- 2 University of MiamiUnited States 24 works
- 3 Memorial Sloan Kettering Cancer CenterUnited States 20 works
- 4 Harvard UniversityUnited States 17 works
- 5 Cleveland ClinicUnited States 16 works
- 6 Brigham and Women's HospitalUnited States 15 works
- 7 The University of Texas Southwestern Medical CenterUnited States 15 works
- 8 University of PennsylvaniaUnited States 15 works
- 9 All India Institute of Medical SciencesIndia 14 works
- 10 Mayo Clinic in ArizonaUnited States 14 works
Who are the leading researchers in Nonmelanoma Skin Cancer Studies?
The most-cited researchers publishing on Nonmelanoma Skin Cancer Studies include Dirk Schadendorf and Caroline Robert.
- 1 Dirk Schadendorf Germany 4.4k citations
- 2 Caroline Robert France 3.3k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Nonmelanoma Skin Cancer Studies research done?
The largest centres of Nonmelanoma Skin Cancer Studies research in 2022–2025 are New York (United States), London (United Kingdom), São Paulo (Brazil) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Coral Gables.
Largest cities, 2022–2025
- 1 New York United States 81 works
- 2 London United Kingdom 63 works
- 3 São Paulo Brazil 56 works
- 4 Shanghai China 51 works
- 5 Houston United States 49 works
- 6 Boston United States 47 works
- 7 Philadelphia United States 47 works
- 8 Beijing China 46 works
- 9 Chennai India 44 works
- 10 Cleveland United States 43 works
Where it is the local speciality
- Coral GablesUS · 24.4 works9.7×
Location quotient: how much more of its research is in Nonmelanoma Skin Cancer Studies than the world average.
Where is the best place to study Nonmelanoma Skin Cancer Studies?
Among universities, judged by research, University of Miami, Harvard University and The University of Queensland score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University of MiamiUnited States | 70.4 | 12.6% | 9.9× | 24 | +82.6% |
| 2 | Harvard UniversityUnited States | 51.2 | 18.0% | 2.6× | 17 | +43.8% |
| 3 | The University of QueenslandAustralia | 46.5 | 17.5% | 3.1× | 13 | +16.2% |
| 4 | University of PennsylvaniaUnited States | 45.6 | 11.4% | 3.2× | 15 | +139.9% |
| 5 | Stanford UniversityUnited States | 41.6 | 14.4% | 2.1× | 13 | +87.8% |
| 6 | University of California, San FranciscoUnited States | 39.7 | 13.9% | 3.3× | 11 | +76.5% |
| 7 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 36.7 | 11.3% | 1.9× | 9 | +231.7% |
| 8 | The University of SydneyAustralia | 34.2 | 12.5% | 2.5× | 12 | -10.2% |
| 9 | Baylor College of MedicineUnited States | 33.1 | 6.0% | 6.5× | 13 | -31.0% |
| 10 | Sichuan UniversityChina | 33.1 | 21.6% | 0.9× | 8 | +4.3% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Nonmelanoma Skin Cancer Studies research growing?
Output in 2018–2022 was 39% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Nonmelanoma Skin Cancer Studies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.